Nivolumab

• Target:

  PD-1/PD-L1

• Related Pathways:

  Cell Cycle/Checkpoint|||Immunology/Inflammation|||Apoptosis

• Purity:

  0.98

• Bioactivity:

  Nivolumab is a monoclonal antibody and is a humanized PD-1 antibody. Nivolumab has anti-tumor activity and is used in the treatment of melanoma, non-small cell lung cancer, renal cell carcinoma, etc.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  946414-94-4